4.3 Article

Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents

Related references

Note: Only part of the references are listed.
Review Surgery

Induction therapy in heart transplantation: where are we now?

Arezu Aliabadi et al.

TRANSPLANT INTERNATIONAL (2013)

Article Cardiac & Cardiovascular Systems

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices?

Jeremiah G. Allen et al.

ANNALS OF THORACIC SURGERY (2012)

Article Cardiac & Cardiovascular Systems

Histologic and functional evaluation of lungs reconditioned by ex vivo lung perfusion

Israel Lopes Medeiros et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)

Article Cardiac & Cardiovascular Systems

Lung transplantation in patients 70 years old or older: Have outcomes changed after implementation of the lung allocation score?

Arman Kilic et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)

Article Surgery

Alemtuzumab for cytolytic induction of immunosuppression in heart transplant recipients

William D. Cahoon et al.

PROGRESS IN TRANSPLANTATION (2012)

Article Cardiac & Cardiovascular Systems

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis

Bryan A. Whitson et al.

ANNALS OF THORACIC SURGERY (2011)

Editorial Material Cardiac & Cardiovascular Systems

Scientific Registry of the International Society for Heart and Lung Transplantation: Introduction to The 2011 Annual Reports

Marshall I. Hertz et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)

Editorial Material Cardiac & Cardiovascular Systems

The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report-2010

Josef Stehlik et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)

Article Immunology

Induction Immunosuppression With Basiliximab in Heart Transplantation

N. K. Chou et al.

TRANSPLANTATION PROCEEDINGS (2008)

Article Cardiac & Cardiovascular Systems

Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thyrnocyte globulin as induction therapy

Marie Francoise Mattei et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)

Article Cardiac & Cardiovascular Systems

To induce or not to induce: Do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?

R Higgins et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)